FDA inspection
Bioreliance Ltd.: FDA inspection ending Nov 7, 2023
FDA inspection 1225550 · No Action Indicated (NAI) · Glasgow
Key facts
| Inspection ID | 1225550 |
|---|---|
| Firm | Bioreliance Ltd. |
| FEI number | 3005343934 |
| Address | Todd Campus, West Of Scotland Science Park |
| City | Glasgow |
| Country | United Kingdom |
| Fiscal year | 2024 |
| Inspection end date | Nov 7, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Vaccines and Allergenic Products |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data